menu

The Quest to Better Understand Axial Psoriatic Arthritis

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Quest to Better Understand Axial Psoriatic Arthritis

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

How can we accurately diagnose axPsA if it’s not commonly understood, and is it distinct enough from coexisting conditions to stand on its own?

  • Sponsored by

  • Overview

    Axial psoriatic arthritis (axPsA) is a challenging clinical entity to characterize, with a prevalence ranging anywhere between 12.5% and 78% of psoriatic arthritis patients because of varied definitions and inclusion criteria. To learn more about how we can better define and diagnose axPsA, Dr. Matt Birnholz is joined by Dr. Alexis Ogdie, Associate Professor of Medicine and Epidemiology at the University of Pennsylvania.

    4/21     M-XAT-1400586

Schedule22 Oct 2021
Webpack App